KA

Karthik Ardhanareeswaran

Partner at GV

Cambridge, Massachusetts

VC
Investor

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $250,000.00

  • Max Investment:

    $50,000,000.00

  • Target Investment:

    $25,000,000.00

Education

Lists including Karthik

AP
AO
AS
AN

Based in UK

1884 people

AM
AR
AB
AF

Based in Boston & Cambridge

668 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

G
GV

2022

  • Partner

    2022

    Therapeutics and Drug Discovery

TD
The D. E. Shaw Group

2015 - 2022

  • Vice President / Quant

    2020 - 2022

  • Quant

    2018 - 2019

  • Strategy

    2015 - 2018

  • Trader/Analyst, Low Latency Options

    2016 - 2017

YS
Yale School of Medicine

2012 - 2015

  • Researcher, Stem Cell Bioinformatics and Neurodevelopment

    2012 - 2015

    https://www.ncbi.nlm.nih.gov/pubmed/?term=Karthikeyan+Ardhanareeswaran MS Candidate, Program in Neurodevelopment and Regeneration - Vaccarino Lab (2013-2015) Clinical Research Assistant, Yale Autism Program - Volkmar Lab (2012-2014)

G
Genentech

2014 - 2014

  • Oncology R&D Intern

    2014 - 2014

J&
Johnson & Johnson

2013 - 2013

  • Neuroscience R&D Intern

    2013 - 2013

DU
Duke University School of Medicine

2012 - 2013

  • Researcher, Stem Cell Bioinformatics

    2012 - 2013

    Dzau/Mirotsou Lab - Department of Medicine (Cardiology)